209 related articles for article (PubMed ID: 23451100)
1. Adherence to chemoprophylaxis and Plasmodium falciparum anti-circumsporozoite seroconversion in a prospective cohort study of Dutch short-term travelers.
Belderok SM; van den Hoek A; Roeffen W; Sauerwein R; Sonder GJ
PLoS One; 2013; 8(2):e56863. PubMed ID: 23451100
[TBL] [Abstract][Full Text] [Related]
2. Testing for anti-circumsporozoite and anti-blood-stage antibodies for epidemiologic assessment of Plasmodium falciparum infection in travelers.
Cobelens FG; Verhave JP; Leentvaar-Kuijpers A; Kager PA
Am J Trop Med Hyg; 1998 Jan; 58(1):75-80. PubMed ID: 9452296
[TBL] [Abstract][Full Text] [Related]
3. Malaria in long-term travelers: Infection risks and adherence to preventive measures - A prospective cohort study.
Suryapranata FST; Overbosch FW; Matser A; Grobusch MP; McCall MBB; van Rijckevorsel GGC; Prins M; Sonder GJB
Travel Med Infect Dis; 2022; 49():102406. PubMed ID: 35934313
[TBL] [Abstract][Full Text] [Related]
4. Seroconversion to circumsporozoite antigen of Plasmodium falciparum demonstrates a high risk of malaria transmission in travelers to East Africa.
Nothdurft HD; Jelinek T; Blüml A; von Sonnenburg F; Löscher T
Clin Infect Dis; 1999 Mar; 28(3):641-2. PubMed ID: 10194093
[TBL] [Abstract][Full Text] [Related]
5. Malaria Surveillance - United States, 2016.
Mace KE; Arguin PM; Lucchi NW; Tan KR
MMWR Surveill Summ; 2019 May; 68(5):1-35. PubMed ID: 31099769
[TBL] [Abstract][Full Text] [Related]
6. Malaria Surveillance - United States, 2015.
Mace KE; Arguin PM; Tan KR
MMWR Surveill Summ; 2018 May; 67(7):1-28. PubMed ID: 29723168
[TBL] [Abstract][Full Text] [Related]
7. Malaria Surveillance - United States, 2014.
Mace KE; Arguin PM
MMWR Surveill Summ; 2017 May; 66(12):1-24. PubMed ID: 28542123
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of antibodies against circumsporozoite antigen of Plasmodium falciparum without development of symptomatic malaria in travelers returning from sub-Saharan Africa.
Jelinek T; Löscher T; Nothdurft HD
J Infect Dis; 1996 Dec; 174(6):1376-9. PubMed ID: 8940239
[TBL] [Abstract][Full Text] [Related]
9. Assessing the incidence of infection with Plasmodium falciparum among international travelers.
Jelinek T; Blüml A; Löscher T; Nothdurft HD
Am J Trop Med Hyg; 1998 Jul; 59(1):35-7. PubMed ID: 9684623
[TBL] [Abstract][Full Text] [Related]
10. Chemoprophylaxis according to the guidelines on malaria prevention for Japanese overseas travelers.
Mizuno Y; Kudo K; Kano S
Southeast Asian J Trop Med Public Health; 2006; 37 Suppl 3():11-4. PubMed ID: 17547042
[TBL] [Abstract][Full Text] [Related]
11. Malaria Disease and Chemoprophylaxis Usage among Israeli Travelers to Endemic Countries.
Harel R; Chazan B; Schwartz E
Am J Trop Med Hyg; 2020 Jun; 102(6):1351-1357. PubMed ID: 32274987
[TBL] [Abstract][Full Text] [Related]
12. Adherence to antimalarial chemoprophylaxis among Israeli travelers visiting malaria-endemic areas.
Khoury S; Kaplan S; Zaidenstein R; Cohen E; Tischler-Aurkin D; Sheffer R; Mathew L; Mor Z
Travel Med Infect Dis; 2021; 44():102193. PubMed ID: 34728384
[TBL] [Abstract][Full Text] [Related]
13. Malaria chemoprophylaxis advice: survey of South African community pharmacists' knowledge and practices.
Toovey S
J Travel Med; 2006; 13(3):161-5. PubMed ID: 16706947
[TBL] [Abstract][Full Text] [Related]
14. Plasmodium falciparum: use of a NANP19 antibody-test for the detection of infection in non-immune travellers.
Knappik M; Peyerl-Hoffmann G; Jelinek T
Trop Med Int Health; 2002 Aug; 7(8):652-6. PubMed ID: 12167092
[TBL] [Abstract][Full Text] [Related]
15. Compliance with malaria chemoprophylaxis and preventative measures against mosquito bites among Dutch travellers.
Cobelens FG; Leentvaar-Kuijpers A
Trop Med Int Health; 1997 Jul; 2(7):705-13. PubMed ID: 9270740
[TBL] [Abstract][Full Text] [Related]
16. Antibody responses to several malaria pre-erythrocytic antigens as a marker of malaria exposure among travelers.
Orlandi-Pradines E; Penhoat K; Durand C; Pons C; Bay C; Pradines B; Fusai T; Josse R; Dubrous P; Meynard JB; Durand JP; Migliani R; Boutin JP; Druilhe P; Rogier C
Am J Trop Med Hyg; 2006 Jun; 74(6):979-85. PubMed ID: 16760507
[TBL] [Abstract][Full Text] [Related]
17. The safety and tolerance of atovaquone/proguanil for the long-term prophylaxis of plasmodium falciparum malaria in non-immune travelers and expatriates [corrected].
van Genderen PJ; Koene HR; Spong K; Overbosch D
J Travel Med; 2007; 14(2):92-5. PubMed ID: 17367478
[TBL] [Abstract][Full Text] [Related]
18. Malaria protection measures used by in-flight travelers to South African game parks.
Waner S; Durrhiem D; Braack LE; Gammon S
J Travel Med; 1999 Dec; 6(4):254-7. PubMed ID: 10575175
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of chemoprophylaxis against malaria with chloroquine plus proguanil, mefloquine, and atovaquone plus proguanil in travelers from Denmark.
Kofoed K; Petersen E
J Travel Med; 2003; 10(3):150-4. PubMed ID: 12757688
[TBL] [Abstract][Full Text] [Related]
20. Malaria surveillance--United States, 2012.
Cullen KA; Arguin PM;
MMWR Surveill Summ; 2014 Dec; 63(12):1-22. PubMed ID: 25474160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
